Literature DB >> 1393116

Cortical blindness after nifedipine treatment.

C Morton1, M Hickey-Dwyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1393116      PMCID： PMC1882925          DOI： 10.1136/bmj.305.6855.693-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Occipital cortical "angina" induced by nifedipine.

Authors:  M Bulling; R Burns
Journal:  Med J Aust       Date:  1988-03-07       Impact factor: 7.738

3.  Oral nifedipine in the treatment of hypertensive urgency: cerebrovascular accident following a single dose.

Authors:  M Schwartz; J E Naschitz; D Yeshurun; B Sharf
Journal:  Arch Intern Med       Date:  1990-03

4.  Cerebral ischaemia after nifedipine treatment.

Authors:  E Nobile-Orazio; R Sterzi
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-10
  4 in total
  4 in total

1.  On redefining hypertension.

Authors:  Michel Accad; Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2010

Review 2.  The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles.

Authors:  Vincent Van den Eynde; Peter Kenneth Gillman; Barry B Blackwell
Journal:  Psychopharmacol Bull       Date:  2022-05-31

Review 3.  A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.

Authors:  Peter Kenneth Gillman
Journal:  J Neural Transm (Vienna)       Date:  2018-09-25       Impact factor: 3.575

4.  Oral short-acting antihypertensive medications and the occurrence of stroke: a nationwide case-crossover study.

Authors:  Chia-Yu Hsu; Ling-Ya Huang; Jeffrey L Saver; Yi-Ling Wu; Jiann-Der Lee; Pei-Chun Chen; Meng Lee; Bruce Ovbiagele
Journal:  Hypertens Res       Date:  2019-07-12       Impact factor: 3.872
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.